These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 11109302)
1. What is the best approach to management of acute depression in bipolar disorder? Joffe RT; MacQueen GM; Young LT J Psychiatry Neurosci; 2000 Nov; 25(5):516. PubMed ID: 11109302 [No Abstract] [Full Text] [Related]
2. [Biological treatment of acute depressive episodes]. Schmauss M; Messer T Fortschr Neurol Psychiatr; 2007 Oct; 75(10):617-27; quiz 628-30. PubMed ID: 17914677 [No Abstract] [Full Text] [Related]
4. What is the best treatment for bipolar depression? Young LT J Psychiatry Neurosci; 2008 Nov; 33(6):487-8. PubMed ID: 18982170 [No Abstract] [Full Text] [Related]
5. On being bipolar without being bipolar. Goldberg J J Psychopharmacol; 2008 Jun; 22(4):402-3; discussion 408. PubMed ID: 18635717 [No Abstract] [Full Text] [Related]
6. [Psychosocial adjustment of unipolar and bipolar patients]. Escande M; Gavarret P; Charlet JP Encephale; 1995 Dec; 21 Spec No 4():55-9. PubMed ID: 8808348 [No Abstract] [Full Text] [Related]
7. [Psychopathological and neurophysiological indicators in endogenous depression and the therapeutic effect of thymoleptics. I. Analysis of the clinical effect of antidepressive drugs with various pharmacological profiles]. Twarowska-Hauser J; Strzyzewksi W; Chłopocka-Woźniak M; Markowski S; Nowakowska C; Rajewski A; Rozek B; Sydor L; Zelechowska-Ruda E Psychiatr Pol; 1985; 19(5):357-62. PubMed ID: 3913975 [No Abstract] [Full Text] [Related]
8. The modern pharmacopoeia: a return to depressive realism? Goldberg JF Bipolar Disord; 2008 Dec; 10(8):969-72. PubMed ID: 19594511 [No Abstract] [Full Text] [Related]
9. [Psychopathological and neurophysiological indicators in endogenous depression and the therapeutic effect of thymoleptics. II. Comparison of the effects of various thymoleptics on the psychopathological symptoms of endogenous depressive syndromes]. Strzyzewski W; Twarowska-Hauser J; Chłopocka-Woźniak M; Markowski S; Nowakowska C; Rajewski A; Rozek B; Sydor L; Zelechowska-Ruda E Psychiatr Pol; 1985; 19(5):363-9. PubMed ID: 3913976 [No Abstract] [Full Text] [Related]
10. [Personality disorders and use of antidepressants]. Brochier T Encephale; 1994 Jun; 20 Spec No 2():267-8. PubMed ID: 8088244 [No Abstract] [Full Text] [Related]
11. Antidepressant monotherapy in pre-bipolar depression; predictive value and inherent risk. O'Donovan C; Garnham JS; Hajek T; Alda M J Affect Disord; 2008 Apr; 107(1-3):293-8. PubMed ID: 17850879 [TBL] [Abstract][Full Text] [Related]
12. Upping the ante on antidepressants. Malhi GS Bipolar Disord; 2008 Dec; 10(8):975-8. PubMed ID: 19594513 [No Abstract] [Full Text] [Related]
13. [Clinical criteria for choosing an antidepressive drug]. Manus A Encephale; 1995 Dec; 21 Spec No 4():19-21. PubMed ID: 8808341 [No Abstract] [Full Text] [Related]
14. Medical management of disturbed behaviour. Gannon MA; O'Sullivan P Ir Med J; 1998 Dec; 91(6):197. PubMed ID: 10069125 [No Abstract] [Full Text] [Related]
16. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression. Ghaemi SN Bipolar Disord; 2008 Dec; 10(8):957-68. PubMed ID: 19594510 [TBL] [Abstract][Full Text] [Related]
17. Antidepressant treatment practice in the face of STAR*D and STEP-BD. Cassidy F Bipolar Disord; 2008 Dec; 10(8):973-4. PubMed ID: 19594512 [No Abstract] [Full Text] [Related]